Correlates of left atrial size in hypertensive patients with left ventricular hypertrophy: The Losartan Intervention For Endpoint reduction in hypertension (LIFE) study

Hypertension

Volumn 39, Issue 3, 2002, Pages 739-743

  Gerdts, Eva ^a   Oikarinen, Lasse ^a   Palmieri, Vittorio ^a   Otterstad, Jan Erik ^a   Wachtell, Kristian ^a   Boman, Kurt ^a   Dahlöf, Björn ^a   Devereux, Richard B ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Age; Body mass index; Hypertrophy; Left atrial size

Indexed keywords

LOSARTAN;

ADULT; AGE; AGED; ARTICLE; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; HEART ATRIUM FIBRILLATION; HEART EJECTION FRACTION; HEART LEFT ATRIUM; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART STROKE VOLUME; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REGURGITATION; OBESITY; PRIORITY JOURNAL; PULSE PRESSURE; RISK FACTOR; STROKE; SYSTOLIC BLOOD PRESSURE;

AGED; AGED, 80 AND OVER; ELECTROCARDIOGRAPHY; FEMALE; HEART ATRIA; HEMODYNAMIC PROCESSES; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; LOGISTIC MODELS; MALE; MIDDLE AGED;

EID: 0036200321     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/hy0302.105683     Document Type: Article

References (35)

1. Echocardiographic evaluation of cardiac structure and function in elderly subjects with isolated systolic hypertension
2. Pathophysiologic assessment of hypertensive heart disease with echocardiography
3. Electrocardiographic changes reflecting left atrial abnormality in hypertension
4. Clinical-physiological correlations in the development of hypertensive heart disease
5. Left atrial size of hypertensive men: Influence of obesity, race and age
6. Effect of single-drug therapy on reduction of left atrial size in mild to moderate hypertension
7. Left atrial size and the risk of stroke and death: The Framingham Heart study
8. Left atrial size and the risk of ischemic stroke in an ethnically mixed population
9. The Losartan Intervention For Endpoint (LIFE) reduction in hypertension study: Baseline characteristics of 9194 patients with left ventricular hypertrophy
10. Left ventricular wall stresses and wall stress-mass-heart rate products in hypertensive patients with electrocardiographic left ventricular hypertrophy: The Losartan Intervention For Endpoint reduction in hypertension (LIFE) study
11. P wave analysis in valvular heart disease
12. Impact of different partition values on prevalence of left ventricular hypertrophy and concentric geometry in a large hypertensive population: The LIFE study
13. Recommendations regarding quantitation in M-mode echocardiography: Results from a survey of echocardiographic measurements
14. Recommendations for quantification of the left ventricle by two-dimensional echocardiography: American Society of Echocardiography Committee on Standards: Subcommittee on Quantification of Two-Dimensional Echocardiograms
15. Reference values for echocardiographic left ventricular measurements in urban and rural populations of differing ethnicity: The Strong Heart study
16. Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings
17. Reliability of echocardiographic assessment of left ventricular structure and function: The PRESERVE study
18. Comparison of enalapril versus nifedipine to decrease left ventricular hypertrophy in systemic hypertension (the PRESERVE trial)
19. Reliable estimation of peak left ventricular systolic pressure by M-mode echocardiographic-determined end-diastolic relative wall thickness: Identification of severe valvular aortic stenosis in adult patients
20. Relation of arterial structure and function to left ventricular geometric patterns in hypertensive adults
21. Assessment of left ventricular function by midwall fractional shortening/end-systolic stress relation in human hypertension
22. Stress-shortening relations and myocardial blood flow in compensated and failing canine hearts with pressure-overload hypertrophy
23. Left ventricular stress and compliance in man: With special reference to normalized function curves
24. Comparative accuracy of Doppler echocardiographic methods for clinical stroke volume determination
25. Prognostic significance of abnormal peak early to late diastolic filling ratio in middle-aged to elderly American Indians: The Strong Heart study
26. Relations of diastolic left ventricular filling to systemic chamber contractility in hypertensive patients with left ventricular hypertrophy: The PRESERVE study
27. Prevalence and correlates of mitral regurgitation in a population-based sample: The Strong Heart study
28. Borderline hypertension and obesity: Two prehypertensive states with elevated cardiac output
29. Stroke volume and cardiac output in normotensive children and adults: Assessment of relations with body size and impact of overweight
30. Factors influencing left ventricular mass in salt sensitive and salt resistant essential hypertensive patients
31. Relation of blood pressure and body build to left ventricular mass in normotensive and hypertensive employed adults
32. Influence of blood pressure on left atrial size: The Framingham Heart study
33. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: Population-based estimates
34. Clinical study to investigate the predictive parameters for the onset of atrial fibrillation in patients with essential hypertension
35. Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation: The Framingham Heart study